657. Combination Therapy with Cyclophosphamide and the Oncolytic Herpes Virus Mutant rRp450, Expressing a Cyclophosphamide Prodrug, Is Clinically Safe by Intratumoral, Intravenous, and Intracerebral Administration in an HSV-1 Susceptible Mouse Model
Keyword(s):
2021 ◽
Keyword(s):
Keyword(s):
2013 ◽
Vol 97
(4)
◽
pp. 498-503
◽
Keyword(s):
2014 ◽
Keyword(s):
Keyword(s):
Keyword(s):
2007 ◽
Vol 1096
(1)
◽
pp. 89-96
◽